Medical clinics and med spas often take very different approaches to care
What the New Research Shows Published in Nature Medicine in June 2026, the phase 2 EMBRAZE trial examined the combination of tirzepatide and apitegromab, an investigational monoclonal antibody that selectively inhibits myostatin activation
Patients taking GLP-1 receptor agonists had a higher incidence of anemia than those taking SGLT-2 inhibitors
Supplements that claim to shift the pounds and slim our waistlines are understandably attractive, but before you spend, its important to understand the science and whether a particular supplement is appropriate for your circumstances
The product driving those results contains exactly two ingredients: copper tripeptide-1 (GHK-Cu) and a single carrier
GLP1 Muscle Loss Summary Infographic: First, Let's Address the Legitimate Concern The worry about muscle loss with GLP-1 medications is not coming from nowhere